REIC/Dkk-3-encoding adenoviral vector as a potentially effective therapeutic agent for bladder cancer

International Journal of Oncology

Volumn 41, Issue 2, 2012, Pages 559-564

  Hirata, Takeshi ^a   Watanabe, Masami ^a   Kaku, Haruki ^a   Kobayashi, Yasuyuki ^a   Yamada, Hiroshi ^a   Sakaguchi, Masakiyo ^a   Takei, Kohji ^a   Huh, Nam Ho ^a   Nasu, Yasutomo ^a   Kumon, Hiromi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bladder cancer; C Jun NH2 kinase; P glycoprotein; Reduced expression in immortalized cells Dickkopf 3

Indexed keywords

ADENOVIRUS VECTOR; DKK 3 PROTEIN; DOXORUBICIN; GLYCOPROTEIN P; STRESS ACTIVATED PROTEIN KINASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOVIRIDAE; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE THERAPY; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; P-GLYCOPROTEIN; URINARY BLADDER NEOPLASMS;

EID: 84863599949     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1503     Document Type: Article

References (26)

1. Dobruch J and Herr H: Should all patients receive single chemotherapeutic agent instillation after bladder tumour resection? BJU Int 104: 170-174, 2009.
2. Kurth KH, Bouffioux C, Sylvester R, van der Meijden AP, Oosterlinck W and Brausi M: Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol 37 (Suppl 3): 1-9, 2000. (Pubitemid 30248573)
3. Tsuji T, Miyazaki M, Sakaguchi M, Inoue Y and Namba M: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268: 20-24, 2000. (Pubitemid 30116603)
4. Tsuji T, Nozaki I, Miyazaki M, Sakaguchi M, Pu H, Hamazaki Y, Iijima O and Namba M: Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun 289: 257-263, 2001. (Pubitemid 33108824)
5. Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirusmediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res 65: 9617-9622, 2005. (Pubitemid 41541434)
6. Abarzua F, Sakaguchi M, Tanimoto R, Sonegawa H, Li DW, Edamura K, Kobayashi T, Watanabe M, Kashiwakura Y, Kaku H, Saika T, Nakamura K, Nasu Y, Kumon H and Huh NH: Heat shock proteins play a crucial role in tumor-specific apoptosis by REIC/Dkk-3. Int J Mol Med 20: 37-43, 2007.
7. Edamura K, Nasu Y, Takaishi M, Kobayashi T, Abarzua F, Sakaguchi M, Kashiwakura Y, Ebara S, Saika T, Watanabe M, Huh NH and Kumon H: Adenovirus-mediated REIC/Dkk-3 gene transfer inhibits tumor growth and metastasis in an orthotopic prostate cancer model. Cancer Gene Ther 14: 765-772, 2007. (Pubitemid 47262756)
8. Watanabe M, Kashiwakura Y, Huang P, Ochiai K, Futami J, Li SA, Takaoka M, Nasu Y, Sakaguchi M, Huh NH and Kumon H: Immunological aspects of REIC/Dkk-3 in monocyte differentiation and tumor regression. Int J Oncol 34: 657-663, 2009.
9. Kashiwakura Y, Ochiai K, Watanabe M, Abarzua F, Sakaguchi M, Takaoka M, Tanimoto R, Nasu Y, Huh NH and Kumon H: Downregulation of inhibition of differentiation-1 via activation of activating transcription factor 3 and Smad regulates REIC/Dickkopf-3-induced apoptosis. Cancer Res 68: 8333-8341, 2008.
10. Tanimoto R, Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kumon H and Huh NH: REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. Int J Mol Med 19: 363-368, 2007.
11. Jin Y, Murata H, Sakaguchi M, Kataoka K, Watanabe M, Nasu Y, Kumon H and Huh NH: Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1. Oncol Rep 27: 695-699, 2012.
12. Zincke H, Utz DC, Taylor WF, Myers RP and Leary FJ: Influence of thiotepa and doxorubicin instillation at time of transurethral surgical treatment of bladder cancer on tumor recurrence: a prospective randomized, double blind, controlled trial. J Urol 129: 505-509, 1983. (Pubitemid 13128769)
13. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM and Deeley RG: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992. (Pubitemid 23012438)
14. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993. (Pubitemid 23237876)
15. Zhou J, Liu M, Aneja R, Chandra R, Lage H and Joshi HC: Reversal of P-glycoprotein-mediated multidrug resistance in cancer cells by the c-Jun NH2-terminal kinase. Cancer Res 66: 445-452, 2006. (Pubitemid 43166053)
16. Kimiya K, Naito S, Soejima T, Sakamoto N, Kotoh S, Kumazawa J and Tsuruo T: Establishment and characterization of doxorubicin-resistant human bladder cancer cell line, KK47/ADM. J Urol 148: 441-445, 1992.
17. Abarzua F, Kashiwakura Y, Takaoka M, Watanabe M, Ochiai K, Sakaguchi M, Iwawaki T, Tanimoto R, Nasu Y, Huh NH and Kumon H: An N-terminal 78 amino acid truncation of REIC/ Dkk-3 effectively induces apoptosis. Biochem Biophys Res Commun 375: 614-618, 2008.
18. Belloc F, Dumain P, Boisseau MR, Jalloustre C, Reiffers J, Bernard P and Lacombe F: A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry 17: 59-65, 1994.
19. Maciorowski Z, Delic J, Padoy E, Klijanienko J, Dubray B, Cosset JM, Dumont J, Magdelénat H and Vielh P: Comparative analysis of apoptosis measured by Hoechst and flow cytometry in non-Hodgkin's lymphomas. Cytometry 32: 44-50, 1998. (Pubitemid 28222107)
20. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, Bhagwat SS, Manning AM and Anderson DW: SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686, 2001. (Pubitemid 33115958)
21. Harris AL and Neal DE: Bladder cancer - field versus clonal origin. N Engl J Med 326: 759-761, 1992.
22. Oosterlinck W, Kurth KH, Schroder F, Bultinck J, Hammond B and Sylvester R: A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder. J Urol 149: 749-752, 1993. (Pubitemid 23111060)
23. Solsona E, Iborra I, Ricos JV, Monros JL, Casanova J and Dumont R: Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up. J Urol 161: 1120-1123, 1999. (Pubitemid 29426099)
24. Naito S, Sakamoto N, Kotoh S, Goto K, Matsumoto T and Kumazawa J: Correlation between the expression of P-glycoprotein and multidrug-resistant phenotype in transitional cell carcinoma of the urinary tract. Eur Urol 22: 158-162, 1992.
25. Sakaguchi M, Kataoka K, Abarzua F, Tanimoto R, Watanabe M, Murata H, Than SS, Kurose K, Kashiwakura Y, Ochiai K, Nasu Y, Kumon H and Huh NH: Overexpression of REIC/Dkk-3 in normal fibroblasts suppresses tumor growth via induction of interleukin-7. J Biol Chem 284: 14236-14244, 2009.
26. Kawasaki K, Watanabe M, Sakaguchi M, Ogasawara Y, Ochiai K, Nasu Y, Doihara H, Kashiwakura Y, Huh NH, Kumon H and Date H: REIC/Dkk-3 overexpression downregulates P-glycoprotein in multidrug-resistant MCF7/ADR cells and induces apoptosis in breast cancer. Cancer Gene Ther 16: 65-72, 2009.